Virginia Tech, Doctor of Veterinary
Medicine – 2002
Long Island Veterinary Specialists,
Internship in
Small Animal Medicine & Surgery –
2002-2003
Veterinary Oncology & Hematology
Center, Residency in Oncology –
2003-2005
Joined RBVH in 2006
Director of Oncology Clinic Operations at RBVH
Lecturer at Veterinary Cancer Society (VCS)
Active in Clinical Research at RBVH and author/coauthor of multiple publications
Selective Publications:
M Isotani, O Yamada, JL Lachowicz, et al. Mutations in the fifth immunoglobulin-like domain of kit are common and potentially sensitive to imatinib mesylate in feline mast cell tumours. Br J Haematol 2010; 148(1):144-53.
EM Brodsky, GN Maudlin, JL Lachowicz, GS Post. Asparaginase and MOPP treatment of dogs with lymphoma. J Vet Intern Med 2009; 23(3):578-84.
ML Guzman, RM Rossi, JL Lachowicz, et al. An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells. Blood 2007: 110(13);4427-35.
JL Lachowicz, GS Post, EM Brodsky. A phase I clinical trial evaluating imatinib mesylate (Gleevec) in tumor-bearing cats. J Vet Intern Med 2005; 19(6):860-4.
JL Lachowicz, GS Post, SD Moroff, SC Mooney. Acquired amegakaryocytic thrombocytopenia--four cases and a literature review. J Small Anim Pract 2004; 45(10):507-14.
Red
Bank Veterinary Hospital’s very own Dr. Lachowicz!
- www.joshualouis.com
